dermaOXY skin assay: effect and evidence

Publikation: Bog/antologi/afhandling/rapportRapportFormidling

976 Downloads (Pure)

Resumé

This text is a videnkupon report supported by the Danish Innovation Fonds and conducted by L.M. and B.K. for dermaOXY (by MedicTinedic ApS, Varde, Denmark).
It involves two dermaOXY products: dermaOXY HYALURON SERUM and dermaOXY SYN SERUM. These are applied to the facial skin in combination with a 90 percent pure oxygen gas stream. Occasionally, the treatment is supported by low-level light exposure, prepared by mechanical microporation of skin or both. The dermaOXY skin improvement approach is used in treatments by clinics spread across 23 countries [1]. This text also includes an assessment of the instrument set DermaLab®Combo, which is used for the physical characterization of skin status after treatment.
The report consists of four main parts, dedicated to
1. the properties of human skin
2. the anti-aging methods applied by the dermaOXY treatment
3. the analytical methods applied by dermaOXY to characterize the effects of the
dermaOXY treatment
4. an evaluation of the above
Selected aspects of the human skin are described in order to provide a general
background of knowledge. In more detail: the three layers of skin (epidermis, dermis and hypodermis) and their constituents are described. This knowledge is important for assessing the dermaOXY approach to slow down (or better yet inhibit) the phenotypical signs of aging. Professor Beate Klösgen and B.Sc. Lasse Menov performed the study and wrote this report. Lars Melgaard, COO of dermaOXY, provided the information on the dermaOXY approach. Doris Westphal from Westphals Fabrikker A/S, Sønder-Omme, Denmark kindly supplied data about the sera and their constituents. Additional information was acquired during an open discussion among the above mentioned persons and Lars L. Kristensen from Lambert Kristensen ApS, Esbjerg, Denmark. This exchange of information was organized by L. Melgaard and hosted by D. Westphal.
OriginalsprogEngelsk
Antal sider78
StatusUdgivet - 15 feb. 2015

Fingeraftryk

Skin
Denmark
Subcutaneous Tissue
Dermis
Epidermis
Gases
Oxygen
Serum

Citer dette

@book{2eeef7751fd84645a2ff3590125d11dc,
title = "dermaOXY skin assay: effect and evidence",
abstract = "This text is a videnkupon report supported by the Danish Innovation Fonds and conducted by L.M. and B.K. for dermaOXY (by MedicTinedic ApS, Varde, Denmark). It involves two dermaOXY products: dermaOXY HYALURON SERUM and dermaOXY SYN SERUM. These are applied to the facial skin in combination with a 90 percent pure oxygen gas stream. Occasionally, the treatment is supported by low-level light exposure, prepared by mechanical microporation of skin or both. The dermaOXY skin improvement approach is used in treatments by clinics spread across 23 countries [1]. This text also includes an assessment of the instrument set DermaLab{\circledR}Combo, which is used for the physical characterization of skin status after treatment.The report consists of four main parts, dedicated to1. the properties of human skin2. the anti-aging methods applied by the dermaOXY treatment3. the analytical methods applied by dermaOXY to characterize the effects of thedermaOXY treatment4. an evaluation of the aboveSelected aspects of the human skin are described in order to provide a generalbackground of knowledge. In more detail: the three layers of skin (epidermis, dermis and hypodermis) and their constituents are described. This knowledge is important for assessing the dermaOXY approach to slow down (or better yet inhibit) the phenotypical signs of aging. Professor Beate Kl{\"o}sgen and B.Sc. Lasse Menov performed the study and wrote this report. Lars Melgaard, COO of dermaOXY, provided the information on the dermaOXY approach. Doris Westphal from Westphals Fabrikker A/S, S{\o}nder-Omme, Denmark kindly supplied data about the sera and their constituents. Additional information was acquired during an open discussion among the above mentioned persons and Lars L. Kristensen from Lambert Kristensen ApS, Esbjerg, Denmark. This exchange of information was organized by L. Melgaard and hosted by D. Westphal.",
keywords = "demaOXY, skin treatment, anti-aging",
author = "Lasse Menov and Kl{\"o}sgen-Buchkremer, {Beate Maria}",
year = "2015",
month = "2",
day = "15",
language = "English",

}

dermaOXY skin assay: effect and evidence. / Menov, Lasse; Klösgen-Buchkremer, Beate Maria.

2015. 78 s.

Publikation: Bog/antologi/afhandling/rapportRapportFormidling

TY - RPRT

T1 - dermaOXY skin assay: effect and evidence

AU - Menov, Lasse

AU - Klösgen-Buchkremer, Beate Maria

PY - 2015/2/15

Y1 - 2015/2/15

N2 - This text is a videnkupon report supported by the Danish Innovation Fonds and conducted by L.M. and B.K. for dermaOXY (by MedicTinedic ApS, Varde, Denmark). It involves two dermaOXY products: dermaOXY HYALURON SERUM and dermaOXY SYN SERUM. These are applied to the facial skin in combination with a 90 percent pure oxygen gas stream. Occasionally, the treatment is supported by low-level light exposure, prepared by mechanical microporation of skin or both. The dermaOXY skin improvement approach is used in treatments by clinics spread across 23 countries [1]. This text also includes an assessment of the instrument set DermaLab®Combo, which is used for the physical characterization of skin status after treatment.The report consists of four main parts, dedicated to1. the properties of human skin2. the anti-aging methods applied by the dermaOXY treatment3. the analytical methods applied by dermaOXY to characterize the effects of thedermaOXY treatment4. an evaluation of the aboveSelected aspects of the human skin are described in order to provide a generalbackground of knowledge. In more detail: the three layers of skin (epidermis, dermis and hypodermis) and their constituents are described. This knowledge is important for assessing the dermaOXY approach to slow down (or better yet inhibit) the phenotypical signs of aging. Professor Beate Klösgen and B.Sc. Lasse Menov performed the study and wrote this report. Lars Melgaard, COO of dermaOXY, provided the information on the dermaOXY approach. Doris Westphal from Westphals Fabrikker A/S, Sønder-Omme, Denmark kindly supplied data about the sera and their constituents. Additional information was acquired during an open discussion among the above mentioned persons and Lars L. Kristensen from Lambert Kristensen ApS, Esbjerg, Denmark. This exchange of information was organized by L. Melgaard and hosted by D. Westphal.

AB - This text is a videnkupon report supported by the Danish Innovation Fonds and conducted by L.M. and B.K. for dermaOXY (by MedicTinedic ApS, Varde, Denmark). It involves two dermaOXY products: dermaOXY HYALURON SERUM and dermaOXY SYN SERUM. These are applied to the facial skin in combination with a 90 percent pure oxygen gas stream. Occasionally, the treatment is supported by low-level light exposure, prepared by mechanical microporation of skin or both. The dermaOXY skin improvement approach is used in treatments by clinics spread across 23 countries [1]. This text also includes an assessment of the instrument set DermaLab®Combo, which is used for the physical characterization of skin status after treatment.The report consists of four main parts, dedicated to1. the properties of human skin2. the anti-aging methods applied by the dermaOXY treatment3. the analytical methods applied by dermaOXY to characterize the effects of thedermaOXY treatment4. an evaluation of the aboveSelected aspects of the human skin are described in order to provide a generalbackground of knowledge. In more detail: the three layers of skin (epidermis, dermis and hypodermis) and their constituents are described. This knowledge is important for assessing the dermaOXY approach to slow down (or better yet inhibit) the phenotypical signs of aging. Professor Beate Klösgen and B.Sc. Lasse Menov performed the study and wrote this report. Lars Melgaard, COO of dermaOXY, provided the information on the dermaOXY approach. Doris Westphal from Westphals Fabrikker A/S, Sønder-Omme, Denmark kindly supplied data about the sera and their constituents. Additional information was acquired during an open discussion among the above mentioned persons and Lars L. Kristensen from Lambert Kristensen ApS, Esbjerg, Denmark. This exchange of information was organized by L. Melgaard and hosted by D. Westphal.

KW - demaOXY

KW - skin treatment

KW - anti-aging

M3 - Report

BT - dermaOXY skin assay: effect and evidence

ER -